Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAPO: Denosumab for Severe Oligospermia
NCT06300229Phase 2Completed
- Start
- Mar 2024
- Primary completion
- Jan 2025
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in male infertility, oligospermia. Started Mar 2024; status: completed.
02
Drugs
denosumab
03
Conditions
male infertilityoligospermia
Beyond the preview
Go deeper on NCT06300229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06300229.